BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1088527)

  • 1. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
    Beck ID; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Eosinophilia in acute lymphoblastic leukemia and lymphosarcoma: indicator of immune responses? (author's transl)].
    Kaufmann U; Lampert F
    Klin Padiatr; 1974 Nov; 186(6):492-9. PubMed ID: 4531501
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunopathology in lymphatic systemic diseases].
    Huber H; Huber C; Michlmayr G
    Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
    [No Abstract]   [Full Text] [Related]  

  • 5. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].
    Wehinger H; Karitzky D
    Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subpopulations of the peripheral blood lymphocytes in lymphocytic leukemia and lymphosarcoma].
    Solov'eva EA; Protasova AK; Zubrikhina GN; Medvedeva IA; Kruglova GV
    Probl Gematol Pereliv Krovi; 1978 Oct; 23(10):13-9. PubMed ID: 309604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases.
    Jonsson V
    Scand J Haematol; 1975 Sep; 15(2):109-16. PubMed ID: 1081272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
    Rupniewska ZM; Kniaź M
    Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
    [No Abstract]   [Full Text] [Related]  

  • 10. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma.
    Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
    Invernizzi R
    Minerva Med; 1980 Nov; 71(44):3247-50. PubMed ID: 6935535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evaluation of peripheral blood lymphoid cells in children in remission a year after the cessation of treatment for acute lymphoblastic leukemia and non-Hodgkin's lymphoma type non-B].
    Wylezoł I; Mazur B; Sońta-Jakimczyk D; Olejnik I
    Wiad Lek; 1998; 51 Suppl 4():140-4. PubMed ID: 10731958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant lymphoma--classification and pathophysiological characteristics of neoplastic cells based on the nature of cell membrane].
    Shimoyama M; Minato K; Kimura K
    Nihon Rinsho; 1976 May; 34(5):925-33. PubMed ID: 789941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of thymus-arised lymphatic cells in the peripheral blood in acute leukoses].
    Kruse H; Eggers G; Mix E
    Z Gesamte Inn Med; 1976 Jul; 31(13):485-9. PubMed ID: 1085533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
    Cheţa D; Micu D; Cheţa N
    Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of T and B lymphocytes in different chronic internal diseases with immune processes.
    Mihăilescu E; Micu D; Purice S; Ion V; Miron C; Sighetea E; Constantineanu M; Popescu R
    Med Interne; 1976; 14(3):205-10. PubMed ID: 1088212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of an immunotherapy trial on terminal leukaemic lymphosarcoma.
    Mathé G; Belpomme D; Pouillart P; Schwarzenberg L; Misset JL; Jasmin MC; Musset M; Cattan A; Amiel JL; Schneider M
    Biomedicine; 1975 Dec; 23(10):465-7. PubMed ID: 1063043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of immunosuppressive agents on T and B lymphocytes.
    Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM
    Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.